© 1993 British Society for Rheumatology
research-article |
AUTOANTIBODY TO THE NUCLEAR ANTIGEN RA33: A MARKER FOR EARLY RHEUMATOID ARTHRITIS
*2nd Department of Medicine, Lainz Hospital Vienna, Austria
Ludwig Boltzmann Institute for Rheumatology and Balneology Vienna, Austria
2nd Department of Medicine, University of Vienna Vienna, Austria
Correspondence to:
Correspondence to Josef S. Smolen, 2nd Department of Medicine, Lainz Hospital, Wolkersbergenstrasse 1, 1-1130 Vienna, Austria
Sera from 47 patients with early (<3 months) arthritis of any type were investigated for anti-RA33, a new anti-nuclear autoantibody characteristic of RA, and the diagnoses determined within the following 8–14 months. In addition, seven patients with unclassified arthritis of >4 months duration, who were all anti-RA33 positive, were followed for up to 2 years to establish their final rheumatologic diagnoses. Four of 47 early arthritis patients' sera were anti-RA33 positive at the initial evaluation; 14 of these 47 patients (30%) could be classified as RA (according to established criteria) at the final evaluation. All four anti-RA33 positive patients belonged to the RA group (27% of RA patients); of the 33 non-RA patients none had anti-RA33 (P=0.005). Rheumatoid factor was found in four RA (none of whom had anti-RA33), but also in two non-RA patients (P=0.05). Finally, the study involved seven additional patients with longer standing, initially unclassified, anti-RA33 positive arthritis: in all of them a diagnosis of RA could be established within 3 years of disease onset. These results suggest that anti-RA33 helps to discriminate early RA from other forms of early arthritis and, in the absence of an established diagnoses, it is predictive of RA. Its discriminative capacity appears to be better than and complementary to that of RF.
KEY WORDS: Rheumatoid arthritis, Early diagnosis, Autoantibody
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. H. Hoffmann, J. Tuncel, K. Skriner, M. Tohidast-Akrad, B. Turk, S. Pinol-Roma, G. Serre, G. Schett, J. S. Smolen, R. Holmdahl, et al. The Rheumatoid Arthritis-Associated Autoantigen hnRNP-A2 (RA33) Is a Major Stimulator of Autoimmunity in Rats with Pristane-Induced Arthritis J. Immunol., December 1, 2007; 179(11): 7568 - 7576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gobezie, P. J. Millett, D. S. Sarracino, C. Evans, and T. S. Thornhill Proteomics: Applications to the Study of Rheumatoid Arthritis and Osteoarthritis J. Am. Acad. Ortho. Surg., June 1, 2006; 14(6): 325 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hayer, M. Tohidast-Akrad, S. Haralambous, B. Jahn-Schmid, K. Skriner, S. Trembleau, H. Dumortier, S. Pinol-Roma, K. Redlich, G. Schett, et al. Aberrant Expression of the Autoantigen Heterogeneous Nuclear Ribonucleoprotein-A2 (RA33) and Spontaneous Formation of Rheumatoid Arthritis-Associated Anti-RA33 Autoantibodies in TNF-{alpha} Transgenic Mice J. Immunol., December 15, 2005; 175(12): 8327 - 8336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Aletaha, G Eberl, V P K Nell, K P Machold, and J S Smolen Attitudes to early rheumatoid arthritis: changing patterns. Results of a survey Ann Rheum Dis, October 1, 2004; 63(10): 1269 - 1275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Bodman-Smith, V. M. Corrigall, E. Berglin, H. R. Cornell, A. G. Tzioufas, C. P. Mavragani, C. Chan, S. Rantapaa-Dahlqvist, and G. S. Panayi Antibody response to the human stress protein BiP in rheumatoid arthritis Rheumatology, October 1, 2004; 43(10): 1283 - 1287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Vencovsky, S Machacek, L Sedova, J Kafkova, J Gatterova, V Pesakova, and S Ruzickova Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis Ann Rheum Dis, May 1, 2003; 62(5): 427 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Fritsch, D. Eselbock, K. Skriner, B. Jahn-Schmid, C. Scheinecker, B. Bohle, M. Tohidast-Akrad, S. Hayer, J. Neumuller, S. Pinol-Roma, et al. Characterization of Autoreactive T Cells to the Autoantigens Heterogeneous Nuclear Ribonucleoprotein A2 (RA33) and Filaggrin in Patients with Rheumatoid Arthritis J. Immunol., July 15, 2002; 169(2): 1068 - 1076. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Hayem, M De Bandt, E Palazzo, S Roux, B Combe, J F Eliaou, J Sany, M F Kahn, and O Meyer Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritis Ann Rheum Dis, May 1, 1999; 58(5): 291 - 296. [Abstract] [Full Text]
|
|
|
|
|
|
F. Ukaji, I. Kitajima, T. Kubo, C. Shimizu, T. Nakajima, and I. Maruyama Serum samples of patients with rheumatoid arthritis contain a specific autoantibody to "denatured" aldolase A in the osteoblast-like cell line, MG-63 Ann Rheum Dis, March 1, 1999; 58(3): 169 - 174. [Abstract] [Full Text]
|
|